Clinical Trial Update: IO vs IV Vancomycin in Tourniquetless TKA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing intraosseous (IO) versus intravenous (IV) vancomycin in tourniquetless total knee arthroplasty (TKA) for surgical site i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection
• Surgical Site Infection
• Total Knee Arthroplasty

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Infection, Surgical Site | Phase 4 | Status: UNKNOWN